Cellbricks
Health Care · Biotechnology
1hiring now · open roles
Venture roundlatest round · Mar 2026 · 8 mo ago
2backers · better ventures, VU Venture Partners
$3.6Mgrants · 7 grants · CORDIS
Overview
Cellbricks Therapeutics is a biotechnology company that produces bioengineered, implantable human tissue to restore organ and tissue function for patients. Its job ad seeks a head of finance and investor relations on a CFO track, working on site. The company is headquartered in Berlin, Germany.
Funding and backers
Latest round
Venture round
Mar 2026 · 8 mo ago
Team
11-50
employees, estimated range
Hiring now
1
open roles
Grants
$3.6M
7 grants · CORDIS
Backers
2
better ventures, VU Venture Partners
The money's age
Fresh money
8 months since the last round · hiring slowed
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 2026
Formerly Cellbricks Therapeutics (cellbricks.com)
Mar 2
Raised a round Venture round
Dec 1, 2023
Won a grant $2M · CORDIS
Feb 1, 2022
Won a grant $409k · CORDIS
Nov 1, 2020
Won a grant $428k · CORDIS
Oct 1, 2020
Won a grant $129k · CORDIS
Aug 1, 2018
Won a grant $313k · CORDIS
Apr 1, 2018
Won a grant $164k · CORDIS
Mar 1, 2017
Won a grant $194k · CORDIS
Jul 20, 2016
Founded per the company register
Funding rounds
Registers and programsofficial lists and records that name the company
| Legal entity | Cellbricks GmbH | de_site |
| Registered | 20 Jul 2016 |
Founders and leadersfrom filings, registers and the company's site
Alexander LeutnerVertreten durchcompany's site
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
We build living human tissue using cells, proteins, and nothing else. Our technology leverages the intersection of personalized medicine…
Istesso is developing adaptive repair medicines which repair and regenerate tissues to treat, resolve and prevent chronic disease and…
Brinter is 3D bioprinting regenerative implants for the $1T tissue repair market. We develop bio-inductive, fully resorbable implants…
CoreBone offers tissue regeneration solutions for Bone and Cartilage from cultivated corals.
Novadip is committed to patients and addresses some of today’s biggest challenges in bone and tissue regenerative medicine.
Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health…
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~17 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Finance
100% ▼
Financials
Total raised
$3.6M
Latest round
Venture - Series Unknown
Funding rounds
8
People
Alexander Leutner
Vertreten durch
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
better venturesVia a fund
VU Venture PartnersVia a fund
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Berlin
Berlin
Germany
HQ
Visit us
1 open roles 1 posted in 90 days 10-50 est. staff
hires for Finance
13353 Berlin, Germany